EUVIMEDOpdag EUVIMED
Crossref

Early prediction of hypotheroidism following 131I treatment for Graves' disease

R Wilson, J H McKillop, E Black, C Jenkins, J A Thomson

European Journal of Nuclear Medicine · 1988-07 · 14 (4)

DOI: 10.1007/bf00257324 ↗

At a glance

Journal article in European Journal of Nuclear Medicine, 1988-07. Written by R Wilson and 4 co-authors. Institution: University Departments of Medicine, Royal Infirmary, Glasgow, UK. Cited 4 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The aim of this study was twofold. Firstly to assess the post treatment predictive value of various biochemical and immunological tests for early hypothyroidism after 131I therapy for Graves' disease, and secondly to determine whether or not pretreatment with Carbimazole protects against post treatment hypothyroidism. The early changes observed in serum T3, T4, TSH, thyroid microsomal and thyroglobulin antibody levels were found to be of no predictive value. A sharp rise, around 2 months, in TRAb levels following 131I therapy indicated that hypothyroidism was likely to occur. This rise was thought to reflect a greater degree of thyroid damage. Lower levels of thyroglobulin in patients who had become hypothyroid by 12 months after treatment would support this view. Five weeks Carbimazole pretreatment in this relatively small group of patients did not appear to protect against hypothyroidism.

Subjects

MeSH terms (MEDLINE)

AntibodiesCarbimazoleFemaleGraves DiseaseHumansHypothyroidismIodine RadioisotopesMalePremedicationReceptors, ThyrotropinThyroid Function TestsTime Factors

Substances

AntibodiesIodine RadioisotopesReceptors, ThyrotropinCarbimazole

Authors and institutions

  • University Departments of Medicine, Royal Infirmary, Glasgow, UK.

Cite

APA

Wilson, R., McKillop, J. H., Black, E., Jenkins, C., & Thomson, J. A. (1988). Early prediction of hypotheroidism following 131I treatment for Graves' disease. European Journal of Nuclear Medicine, 14(4). https://doi.org/10.1007/bf00257324

Vancouver

Wilson R, McKillop JH, Black E, Jenkins C, Thomson JA. Early prediction of hypotheroidism following 131I treatment for Graves' disease. European Journal of Nuclear Medicine. 1988;14(4). doi:10.1007/bf00257324

BibTeX
@article{Wilson1988,
  author = {Wilson, R and McKillop, J H and Black, E and Jenkins, C and Thomson, J A},
  title = {Early prediction of hypotheroidism following 131I treatment for Graves' disease},
  journal = {European Journal of Nuclear Medicine},
  year = {1988},
  volume = {14},
  number = {4},
  doi = {10.1007/bf00257324}
}
Start for free →